Skip to main content
Top
Published in: Endocrine 3/2008

01-06-2008 | Original Paper

Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus)

Authors: Dale Buchanan Hales, Yan Zhuge, Jo Ann Jaen Lagman, Kristine Ansenberger, Cassandra Mahon, Animesh Barua, Judith L. Luborsky, Janice M. Bahr

Published in: Endocrine | Issue 3/2008

Login to get access

Abstract

Cyclooxygenase (COX) (PTGS) is the rate-limiting enzyme in the biosynthesis of prostaglandins. Two COX isoforms have been identified, COX-1 and COX-2, which show distinct cell-specific expression and regulation. Ovarian cancer is the most lethal gynecological malignancy and the disease is poorly understood due to the lack of suitable animal models. The laying hen spontaneously develops epithelial ovarian cancer with few or no symptoms until the cancer has progresses to a late stage, similar to the human disease. The purpose of this study was to examine the relative expression and distribution of COX-1 and COX-2 in the ovaries of normal hens and in hens with ovarian cancer. The results demonstrate that COX-1 was localized to the granulosa cell layer and cortical interstitium, ovarian surface epithelium (OSE) and postovulatory follicle (POF) of the normal ovary. In ovarian cancer, COX-1 mRNA was significantly increased and COX-1 protein was broadly distributed throughout the tumor stroma. COX-2 protein was localized to the granulosa cell layer in the follicle and the ovarian stroma. COX-2 mRNA expression did not change as a function of age or in ovarian cancer. There was significantly higher expression of COX-1 mRNA in the first POF (POF-1) compared to POF-2 and POF-3. COX-2 mRNA expression was not significantly different among POFs. There was no difference in COX-1 or COX-2 mRNA in the OSE isolated from individual follicles in the follicular hierarchy. The results confirm previous findings of the high expression of COX-1 in ovarian tumors further supporting the laying hen as a model for ovarian cancer, and demonstrate for the first time the high expression of COX-1 in POF-1 which is the source of prostaglandins needed for oviposition.
Literature
1.
go back to reference UCSW Group, United States Cancer Statistics: 2002 Incidence and Mortality. (US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2005) UCSW Group, United States Cancer Statistics: 2002 Incidence and Mortality. (US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2005)
3.
go back to reference C. Rodriguez-Burford, M.N. Barnes, W. Berry, E.E. Partridge, W.E. Grizzle, Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol. Oncol. 81, 373–379 (2001)CrossRefPubMed C. Rodriguez-Burford, M.N. Barnes, W. Berry, E.E. Partridge, W.E. Grizzle, Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol. Oncol. 81, 373–379 (2001)CrossRefPubMed
4.
go back to reference J.R. Giles, H.L. Shivaprasad, P.A. Johnson, Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol. Oncol. 95, 530–533 (2004)CrossRefPubMed J.R. Giles, H.L. Shivaprasad, P.A. Johnson, Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol. Oncol. 95, 530–533 (2004)CrossRefPubMed
5.
go back to reference N. Auersperg, A.S. Wong, K.C. Choi, S.K. Kang, P.C. Leung, Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255–288 (2001) N. Auersperg, A.S. Wong, K.C. Choi, S.K. Kang, P.C. Leung, Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255–288 (2001)
6.
go back to reference C.H. Lingeman, Etiology of cancer of the human ovary: a review. J. Natl. Cancer Inst. 53, 1603–1618 (1974)PubMed C.H. Lingeman, Etiology of cancer of the human ovary: a review. J. Natl. Cancer Inst. 53, 1603–1618 (1974)PubMed
7.
go back to reference S. Mabuchi, D.A. Altomare, D.C. Connolly, A. Klein-Szanto, S. Litwin, M.K. Hoelzle, H.H. Hensley, T.C. Hamilton, J.R. Testa, RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res. 67, 2408–2413 (2007)CrossRefPubMed S. Mabuchi, D.A. Altomare, D.C. Connolly, A. Klein-Szanto, S. Litwin, M.K. Hoelzle, H.H. Hensley, T.C. Hamilton, J.R. Testa, RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res. 67, 2408–2413 (2007)CrossRefPubMed
8.
go back to reference T. Daikoku, S. Tranguch, I.N. Trofimova, D.M. Dinulescu, T. Jacks, A.Y. Nikitin, D.C. Connolly, S.K. Dey, Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res. 66, 2527–2531 (2006)CrossRefPubMed T. Daikoku, S. Tranguch, I.N. Trofimova, D.M. Dinulescu, T. Jacks, A.Y. Nikitin, D.C. Connolly, S.K. Dey, Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res. 66, 2527–2531 (2006)CrossRefPubMed
9.
go back to reference D.M. Dinulescu, T.A. Ince, B.J. Quade, S.A. Shafer, D. Crowley, T. Jacks, Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med. 11, 63–70 (2005)CrossRefPubMed D.M. Dinulescu, T.A. Ince, B.J. Quade, S.A. Shafer, D. Crowley, T. Jacks, Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med. 11, 63–70 (2005)CrossRefPubMed
10.
go back to reference S.K. Bristol-Gould, C.G. Hutten, C. Sturgis, S.M. Kilen, K.E. Mayo, T.K. Woodruff, The development of a mouse model of ovarian endosalpingiosis. Endocrinology 146, 5228–5236 (2005)CrossRefPubMed S.K. Bristol-Gould, C.G. Hutten, C. Sturgis, S.M. Kilen, K.E. Mayo, T.K. Woodruff, The development of a mouse model of ovarian endosalpingiosis. Endocrinology 146, 5228–5236 (2005)CrossRefPubMed
11.
go back to reference D.C. Connolly, R. Bao, A.Y. Nikitin, K.C. Stephens, T.W. Poole, X. Hua, S.S. Harris, B.C. Vanderhyden, T.C. Hamilton, Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 63, 1389–1397 (2003)PubMed D.C. Connolly, R. Bao, A.Y. Nikitin, K.C. Stephens, T.W. Poole, X. Hua, S.S. Harris, B.C. Vanderhyden, T.C. Hamilton, Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 63, 1389–1397 (2003)PubMed
12.
go back to reference A. Flesken-Nikitin, K.C. Choi, J.P. Eng, E.N. Shmidt, A.Y. Nikitin, Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 63, 3459–3463 (2003)PubMed A. Flesken-Nikitin, K.C. Choi, J.P. Eng, E.N. Shmidt, A.Y. Nikitin, Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 63, 3459–3463 (2003)PubMed
13.
go back to reference R. Wu, N. Hendrix-Lucas, R. Kuick, Y. Zhai, D.R. Schwartz, A. Akyol, S. Hanash, D.E. Misek, H. Katabuchi, B.O. Williams, E.R. Fearon, K.R. Cho, Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell 11, 321–333 (2007)CrossRefPubMed R. Wu, N. Hendrix-Lucas, R. Kuick, Y. Zhai, D.R. Schwartz, A. Akyol, S. Hanash, D.E. Misek, H. Katabuchi, B.O. Williams, E.R. Fearon, K.R. Cho, Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell 11, 321–333 (2007)CrossRefPubMed
14.
15.
go back to reference D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, H.R. Herschman, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266, 12866–12872 (1991)PubMed D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, H.R. Herschman, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266, 12866–12872 (1991)PubMed
16.
go back to reference C.S. Williams, M. Mann, R.N. DuBois, The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908–7916 (1999)CrossRefPubMed C.S. Williams, M. Mann, R.N. DuBois, The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908–7916 (1999)CrossRefPubMed
17.
go back to reference H.R. Herschman, J.J. Talley, R. DuBois, Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. Mol. Imaging Biol. 5, 286–303 (2003)CrossRefPubMed H.R. Herschman, J.J. Talley, R. DuBois, Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. Mol. Imaging Biol. 5, 286–303 (2003)CrossRefPubMed
18.
go back to reference K. Subbaramaiah, A.J. Dannenberg, Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 24, 96–102 (2003)CrossRefPubMed K. Subbaramaiah, A.J. Dannenberg, Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 24, 96–102 (2003)CrossRefPubMed
19.
go back to reference S.M. Prescott, F.A. Fitzpatrick, Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 1470, M69–78 (2000)PubMed S.M. Prescott, F.A. Fitzpatrick, Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 1470, M69–78 (2000)PubMed
20.
go back to reference W.L. Yang, I.H. Roland, A.K. Godwin, X.X. Xu, Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells. Oncogene 24, 7991–8002 (2005)CrossRefPubMed W.L. Yang, I.H. Roland, A.K. Godwin, X.X. Xu, Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells. Oncogene 24, 7991–8002 (2005)CrossRefPubMed
21.
go back to reference R.A. Gupta, L.V. Tejada, B.J. Tong, S.K. Das, J.D. Morrow, S.K. Dey, R.N. DuBois, Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 63, 906–911 (2003)PubMed R.A. Gupta, L.V. Tejada, B.J. Tong, S.K. Das, J.D. Morrow, S.K. Dey, R.N. DuBois, Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 63, 906–911 (2003)PubMed
22.
go back to reference T. Daikoku, D. Wang, S. Tranguch, J.D. Morrow, S. Orsulic, R.N. DuBois, S.K. Dey, Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 65, 3735–3744 (2005)CrossRefPubMed T. Daikoku, D. Wang, S. Tranguch, J.D. Morrow, S. Orsulic, R.N. DuBois, S.K. Dey, Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 65, 3735–3744 (2005)CrossRefPubMed
23.
go back to reference M.E. Urick, P.A. Johnson, Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol. Oncol. 103, 673–678 (2006)CrossRefPubMed M.E. Urick, P.A. Johnson, Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol. Oncol. 103, 673–678 (2006)CrossRefPubMed
24.
go back to reference S. Li, K. Miner, R. Fannin, J. Carl Barrett, B.J. Davis, Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Gynecol. Oncol. 92, 622–627 (2004)CrossRefPubMed S. Li, K. Miner, R. Fannin, J. Carl Barrett, B.J. Davis, Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Gynecol. Oncol. 92, 622–627 (2004)CrossRefPubMed
25.
go back to reference G. Lee, H.T. Ng, Clinical evaluations of a new ovarian cancer marker, COX-1. Intl. J. Gynaecol. Obstetr. Official Organ Intl. Feder. Gynaecol. Obstetr. 49(Suppl), 27–32 (1995) G. Lee, H.T. Ng, Clinical evaluations of a new ovarian cancer marker, COX-1. Intl. J. Gynaecol. Obstetr. Official Organ Intl. Feder. Gynaecol. Obstetr. 49(Suppl), 27–32 (1995)
26.
go back to reference Y. Kino, F. Kojima, K. Kiguchi, R. Igarashi, B. Ishizuka, S. Kawai, Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins, Leukotrienes, Essential Fatty Acids 73, 103–111 (2005)CrossRef Y. Kino, F. Kojima, K. Kiguchi, R. Igarashi, B. Ishizuka, S. Kawai, Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins, Leukotrienes, Essential Fatty Acids 73, 103–111 (2005)CrossRef
27.
go back to reference J. Bahr, The avian ovary: model for endocrine studies. J. Exp. Zool. 4(Suppl), 192–194 (1990)CrossRef J. Bahr, The avian ovary: model for endocrine studies. J. Exp. Zool. 4(Suppl), 192–194 (1990)CrossRef
28.
go back to reference J.M. Bahr, A.L. Johnson, Regulation of the follicular hierarchy and ovulation. J. Exp. Zool. 232, 495–500 (1984)CrossRefPubMed J.M. Bahr, A.L. Johnson, Regulation of the follicular hierarchy and ovulation. J. Exp. Zool. 232, 495–500 (1984)CrossRefPubMed
29.
go back to reference P.A. Johnson, J.R. Giles, Use of genetic strains of chickens in studies of ovarian cancer. Poult. Sci. 85, 246–250 (2006)PubMed P.A. Johnson, J.R. Giles, Use of genetic strains of chickens in studies of ovarian cancer. Poult. Sci. 85, 246–250 (2006)PubMed
30.
go back to reference J.R. Giles, L.M. Olson, P.A. Johnson, Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp. Biol. Med. 231, 1718–1725 (2006) J.R. Giles, L.M. Olson, P.A. Johnson, Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp. Biol. Med. 231, 1718–1725 (2006)
31.
go back to reference B.C. Vanderhyden, T.J. Shaw, J.F. Ethier, Animal models of ovarian cancer. Reprod. Biol. Endocrinol. 67(1), 1–11 (2003) B.C. Vanderhyden, T.J. Shaw, J.F. Ethier, Animal models of ovarian cancer. Reprod. Biol. Endocrinol. 67(1), 1–11 (2003)
32.
go back to reference M.N. Barnes, W.D. Berry, J.M. Straughn, T.O. Kirby, C.A. Leath, W.K. Huh, W.E. Grizzle, E.E. Partridge, A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol. Oncol. 87, 57–63 (2002)CrossRefPubMed M.N. Barnes, W.D. Berry, J.M. Straughn, T.O. Kirby, C.A. Leath, W.K. Huh, W.E. Grizzle, E.E. Partridge, A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol. Oncol. 87, 57–63 (2002)CrossRefPubMed
33.
go back to reference W.J. Murdoch, J.F. Martinchick, Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp. Biol. Med. (Maywood) 229, 546–552 (2004) W.J. Murdoch, J.F. Martinchick, Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp. Biol. Med. (Maywood) 229, 546–552 (2004)
34.
go back to reference W.J. Murdoch, E.A. Van Kirk, B.M. Alexander, DNA damages in ovarian surface epithelial cells of ovulatory hens. Exp. Biol. Med. (Maywood) 230, 429–433 (2005) W.J. Murdoch, E.A. Van Kirk, B.M. Alexander, DNA damages in ovarian surface epithelial cells of ovulatory hens. Exp. Biol. Med. (Maywood) 230, 429–433 (2005)
35.
go back to reference W.J. Murdoch, R.S. Townsend, A.C. McDonnel, Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol. Reprod. 65, 1417–1424 (2001)CrossRefPubMed W.J. Murdoch, R.S. Townsend, A.C. McDonnel, Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol. Reprod. 65, 1417–1424 (2001)CrossRefPubMed
36.
go back to reference W.J. Murdoch, A.C. McDonnel, Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123, 743–750 (2001)CrossRef W.J. Murdoch, A.C. McDonnel, Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123, 743–750 (2001)CrossRef
37.
go back to reference T.D. Oberley, Oxidative damage and cancer. Am. J. Pathol. 160, 403–408 (2001) T.D. Oberley, Oxidative damage and cancer. Am. J. Pathol. 160, 403–408 (2001)
39.
go back to reference I. Rothchild, R.M. Fraps, On the function of the ruptured ovarian follicle of the domestic fowl. Proc Soc Exp Biol Med N.Y. 56, 79–82 (1944) I. Rothchild, R.M. Fraps, On the function of the ruptured ovarian follicle of the domestic fowl. Proc Soc Exp Biol Med N.Y. 56, 79–82 (1944)
40.
go back to reference J. Bahr, P. Johnson, Reproduction in poulty, in Reproduction in Domestic Animals, ed. P. Cupps (Academic Press, New York, 1991), pp. 555–575 J. Bahr, P. Johnson, Reproduction in poulty, in Reproduction in Domestic Animals, ed. P. Cupps (Academic Press, New York, 1991), pp. 555–575
41.
go back to reference W.Y. Wong, J.S. Richards, Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary. Mol. Endocrinol. 5, 1269–1279 (1991)CrossRefPubMed W.Y. Wong, J.S. Richards, Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary. Mol. Endocrinol. 5, 1269–1279 (1991)CrossRefPubMed
42.
go back to reference A. Hayes, T. Scase, J. Miller, S. Murphy, A. Sparkes, V. Adams, COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J. Comparat. Pathol. 135, 93–99 (2006)CrossRef A. Hayes, T. Scase, J. Miller, S. Murphy, A. Sparkes, V. Adams, COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J. Comparat. Pathol. 135, 93–99 (2006)CrossRef
43.
go back to reference J.S. Richards, D.L. Russell, S. Ochsner, L.L. Espey, Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 64, 69–92 (2002)CrossRefPubMed J.S. Richards, D.L. Russell, S. Ochsner, L.L. Espey, Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 64, 69–92 (2002)CrossRefPubMed
44.
go back to reference U.R. Mbonye, M. Wada, C.J. Rieke, H.-Y. Tang, D.L. DeWitt, W.L. Smith, The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J. Biol. Chem. 281, 35770–35778 (2006) U.R. Mbonye, M. Wada, C.J. Rieke, H.-Y. Tang, D.L. DeWitt, W.L. Smith, The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J. Biol. Chem. 281, 35770–35778 (2006)
45.
go back to reference M. Wada, C.J. Delong, Y.H. Hong, C.J. Rieke, I. Song, R.S. Sidhu, C. Yuan, M. Warnock, A.H. Schmaier, C. Yokoyama, E.M. Smyth, S.J. Wilson, G.A. Fitzgerald, R.M. Garavito, D.X. Sui, J.W. Regan, W.L. Smith, Enzymes and receptors of prostaglandin pathways with arachidonic acid- vs. eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 282, 22254–22266 (2007) M. Wada, C.J. Delong, Y.H. Hong, C.J. Rieke, I. Song, R.S. Sidhu, C. Yuan, M. Warnock, A.H. Schmaier, C. Yokoyama, E.M. Smyth, S.J. Wilson, G.A. Fitzgerald, R.M. Garavito, D.X. Sui, J.W. Regan, W.L. Smith, Enzymes and receptors of prostaglandin pathways with arachidonic acid- vs. eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 282, 22254–22266 (2007)
46.
go back to reference G. Gomori, A rapid one-step trichrome stain. Am. J. Clin. Pathol. 20, 661–664 (1950)PubMed G. Gomori, A rapid one-step trichrome stain. Am. J. Clin. Pathol. 20, 661–664 (1950)PubMed
47.
go back to reference D.C. Skeehan, B.B. Hrapchak, Theory and practice of histological techniques (Mosby, St. Louis, 1973), pp. 111–112 D.C. Skeehan, B.B. Hrapchak, Theory and practice of histological techniques (Mosby, St. Louis, 1973), pp. 111–112
Metadata
Title
Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus)
Authors
Dale Buchanan Hales
Yan Zhuge
Jo Ann Jaen Lagman
Kristine Ansenberger
Cassandra Mahon
Animesh Barua
Judith L. Luborsky
Janice M. Bahr
Publication date
01-06-2008
Publisher
Springer US
Published in
Endocrine / Issue 3/2008
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-008-9080-z

Other articles of this Issue 3/2008

Endocrine 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.